Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

NOMA earnings analysis

Filed August 14, 2026 · Our reading of the company's report

The latest report

The extracted 10-Q does not include the financial statements or MD&A, so current-quarter revenue, margins, EPS, balance-sheet changes, and cash flow cannot be assessed from the provided text. The filing highlights a…

Read full summary

The extracted 10-Q does not include the financial statements or MD&A, so current-quarter revenue, margins, EPS, balance-sheet changes, and cash flow cannot be assessed from the provided text. The filing highlights a financing need, with up to $2,283,800 of stock issuance and a $570,950 initial closing, but also points to potential dilution. Sentiment is bearish because management reported ineffective disclosure controls as of June 30, 2026 and identified material weaknesses in financial-close and reporting oversight. The company reported no material changes to the risk factors in its 2025 Annual Report.

Read the original on SEC.gov

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Nov 2025 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Committed $2.28M Equity Financing

    The company entered into a July 2026 securities purchase agreement for up to $2,283,800 of Class A common stock at $3.65 per share, representing approximately 625,699 shares.

  • Initial $571K Closing Completed

    The initial financing closing on July 29, 2026 raised $570,950. Six additional closings of $285,475 each are scheduled through January 3, 2027, subject to customary conditions.

  • Control Remediation Underway

    The company states that it is undertaking initiatives to remediate internal-control weaknesses, with remediation efforts ongoing as of June 30, 2026.

What to watch

  • Material Control Weaknesses

    Management concluded that disclosure controls and procedures were not effective as of June 30, 2026, citing material weaknesses including insufficient internal review and monitoring of the financial close and reporting process.

  • Potential Equity Dilution

    The July 2026 Offering could issue approximately 625,699 shares for aggregate proceeds of up to $2,283,800, creating meaningful potential dilution to existing holders.

  • Dependence on Future Financing Closings

    The offering limits the investor's beneficial ownership to 9.99% of outstanding common stock, while subsequent tranches of $285,475 are scheduled through January 3, 2027 and remain subject to closing conditions, creating ongoing financing-execution risk.

Management's outlook

No quantitative revenue or EPS guidance was provided in the extracted 10-Q. The filing discusses financing through the July 2026 Offering but does not provide an operating outlook.

Earlier filings 3

10-Q · May 15, 2026

Nomadar Corp. reported a significant increase in revenue for Q1 2026, totaling $403,800, up 116% from $186,937 in Q1 2025. However, the company reported a net loss of $1,586,954, markedly higher than the previous year's…

10-K · March 31, 2026

Nomadar Corp. (NOMA) reported a significant increase in revenues for the year ended December 31, 2025, totaling $921,940, compared to just $8,025 in 2024, driven largely by its High Performance Training (HPT) program…

10-Q · November 21, 2025

Nomadar Corp. reported a revenue increase of 77% year-over-year, generating $877,669 for the nine months ending September 30, 2025. However, the company also experienced significant net losses of $1.41 million due to…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.